HAYWARD, Calif.-LAWFUEL – The Legal Newswire – IMPAX Laboratories, Inc…
HAYWARD, Calif.-LAWFUEL – The Legal Newswire – IMPAX Laboratories, Inc. (OTC:IPXL) today announced that the U.S. District Court for the District of Delaware has ruled that Aventis Pharmaceutical’s patent 5,527,814 related to the use of Rilutek® for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is not invalid on the […]
HAYWARD, Calif.-LAWFUEL – The Legal Newswire – IMPAX Laboratories, Inc… Read More »